PLP1 Protein
Introduction Plp1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
<div class="infobox infobox-protein"> <table> <tr><th colspan="2" style="background: #2c3e50; color: white; text-align: center;">PLP1 Protein</th></tr> <tr><td><strong>Protein Name</strong></td><td>Proteolipid Protein 1 (PLP) / Myelin Proteolipid</td></tr> <tr><td><strong>Gene</strong></td><td>[PLP1](/genes/plp1)</td></tr> <tr><td><strong>UniProt ID</strong></td><td>[P60228](https://www.uniprot.org/uniprot/P60228)</td></tr> <tr><td><strong>Molecular Weight</strong></td><td>~30 kDa (PLP), ~25 kDa (DM20 isoform)</td></tr> <tr><td><strong>Subcellular Localization</strong></td><td>Myelin sheath, oligodendrocyte plasma membrane</td></tr> <tr><td><strong>Protein Family</strong></td><td>Proteolipid protein family</td></tr> <tr> <td class="label">Associated Diseases</td> <td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/dementia" style="color:#ef9a9a">Dementia</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td> </tr> <tr> <td class="label">KG Connections</td> <td><a href="/atlas" style="color:#4fc3f7">78 edges</a></td> </tr> </table> </div>
Overview
...
PLP1 Protein
Introduction Plp1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
<div class="infobox infobox-protein"> <table> <tr><th colspan="2" style="background: #2c3e50; color: white; text-align: center;">PLP1 Protein</th></tr> <tr><td><strong>Protein Name</strong></td><td>Proteolipid Protein 1 (PLP) / Myelin Proteolipid</td></tr> <tr><td><strong>Gene</strong></td><td>[PLP1](/genes/plp1)</td></tr> <tr><td><strong>UniProt ID</strong></td><td>[P60228](https://www.uniprot.org/uniprot/P60228)</td></tr> <tr><td><strong>Molecular Weight</strong></td><td>~30 kDa (PLP), ~25 kDa (DM20 isoform)</td></tr> <tr><td><strong>Subcellular Localization</strong></td><td>Myelin sheath, oligodendrocyte plasma membrane</td></tr> <tr><td><strong>Protein Family</strong></td><td>Proteolipid protein family</td></tr> <tr> <td class="label">Associated Diseases</td> <td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/dementia" style="color:#ef9a9a">Dementia</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td> </tr> <tr> <td class="label">KG Connections</td> <td><a href="/atlas" style="color:#4fc3f7">78 edges</a></td> </tr> </table> </div>
Overview
Mermaid diagram (expand to render)
PLP1 encodes proteolipid protein 1 (PLP), the most abundant protein in central nervous system myelin["@greer2007"]. PLP and its alternatively spliced isoform DM20 are integral membrane proteins that are essential for the formation, stability, and maintenance of the myelin sheath["@inoue2009"]. Mutations in PLP1 cause severe demyelinating disorders including Pelizaeus-Merzbacher disease (PMD). PLP constitutes approximately 50% of total myelin protein and forms the major structural protein of CNS myelin["@greer2007"].
Structure PLP1 is an extremely hydrophobic protein with four transmembrane domains:
| Domain | Residues | Function | |--------|----------|----------| | N-terminal | 1-30 | Cytoplasmic, myristoylation site | | TM1 | 31-59 | First transmembrane helix | | Loop A | 60-89 | Extracellular loop | | TM2 | 90-116 | Second transmembrane helix | | Loop B | 117-147 | Cytoplasmic loop | | TM3 | 148-176 | Third transmembrane helix | | Loop C | 177-200 | Extracellular loop | | TM4 | 201-231 | Fourth transmembrane helix | | C-terminal | 232-276 | Cytoplasmic tail |
PLP1 (276 aa) : Full-length isoform
DM20 (241 aa) : Lacks 35 amino acids (exon 2B), expressed during early development
Normal Function PLP1 is essential for multiple aspects of CNS myelination:
Structural Functions
Myelin formation : Major structural protein of CNS myelin[@greer2007]
Myelin compaction : Helps form the intraperiod line
Oligomerization : Forms multimers that stabilize myelin
Lipid interaction : Binds cholesterol and galactosylceramide
Functional Functions
Axonal support : Metabolic coupling with oligodendrocytes
Long-term axonal integrity : Prevents axonal degeneration
Node of Ranvier : Contributes to nodal organization
Signal transduction : Possible signaling roles
Expression
Highest in mature oligodendrocytes
Expressed in CNS (not PNS)
DM20 isoform predominant in early development
Role in Disease
Pelizaeus-Merzbacher Disease (PMD) X-linked recessive disorder caused by PLP1 mutations[@hobson2006]:
Clinical Forms: | Type | Severity | Onset | |------|----------|-------| | Connatal | Severe | Birth-early infancy | | Classic | Moderate | infancy-childhood | | Null | Severe/lethal | Neonatal |
Pathogenesis:
Failure of CNS myelination (hypomyelination)
Diffuse white matter abnormalities on MRI
Severe neurological impairment
Spastic paraplegia type 2 (SPG2) : Allelic with PMD
Aicardi-Goutières syndrome : Rare PLP1 mutations
Multiple sclerosis : Possible role in demyelination
Neurodegeneration
Axonal degeneration in PLP1-deficient mice
Secondary neurodegeneration in PMD patients
Possible roles in other neurodegenerative diseases
Molecular Mechanisms
Myelin assembly : PLP oligomers form myelin structure
Lipid organization : Interacts with cholesterol and glycolipids
Axonal signaling : Maintains axonal health
Glial-axonal communication : Mediates metabolic support
Therapeutic Approaches | Approach | Status | Details | |----------|--------|---------| | Gene therapy | Clinical trials | AAV-PLP1 delivery | | Cell therapy | Preclinical | Oligodendrocyte transplantation | | Small molecules | Research | Myelin-enhancing compounds | | Symptomatic | Approved | Seizure control, spasticity |
Animal Models
Plp1 knockout mice : Hypomyelination, axonal degeneration
Transgenic models : Expressing mutant PLP1
Humanized models : Expressing human PLP1
Research Directions
Gene therapy optimization : CNS delivery challenges
Axonal protection : Preventing secondary degeneration
Biomarkers : MRI and CSF markers
Combination therapies : Gene + cell therapy
Newborn screening : Early detection
Key Publications
Inoue K. PLP1-related disorders. Brain Dev. 2009;31(7):511-519. PMID: 19328782 (https://pubmed.ncbi.nlm.nih.gov/19328782/)
Greer JM, et al. Proteolipid protein: function and structure. J Neurochem. 2007;103(1):1-10. PMID: 17623052 (https://pubmed.ncbi.nlm.nih.gov/17623052/)
Hobson GM, et al. PLP1 mutations in Pelizaeus-Merzbacher disease. Hum Mutat. 2006;27(11):1065-1069. PMID: 16941468 (https://pubmed.ncbi.nlm.nih.gov/16941468/)
See Also
[PLP1 Gene](/plp1-gene)
[Pelizaeus-Merzbacher Disease](/diseases/pelizaeus-merzbacher-disease)
[Oligodendrocytes](/cell-types/oligodendrocytes)
[Myelin Pathway](/mechanisms/myelin-pathway)
[Multiple Sclerosis](/diseases/multiple-sclerosis)
[Demyelinating Diseases](/diseases/demyelinating-diseases)
External Links
[NCBI Gene: PLP1](https://www.ncbi.nlm.nih.gov/gene/5354)
[UniProt: P60228](https://www.uniprot.org/uniprot/P60228)
[PMD Foundation](https://www.pmdfoundation.org/)
[GeneReviews: PLP1 Disorders](https://www.ncbi.nlm.nih.gov/books/NBK1182/)
Background The study of Plp1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
[Greer JM, et al, Proteolipid protein: function and structure (2007)](https://pubmed.ncbi.nlm.nih.gov/17623052/)
[Inoue K, PLP1-related disorders (2009)](https://pubmed.ncbi.nlm.nih.gov/19328782/)
[Hobson GM, et al, PLP1 mutations in Pelizaeus-Merzbacher disease (2006)](https://pubmed.ncbi.nlm.nih.gov/16941468/)
[Laukka JJ, et al, Axonal degeneration in PLP1-deficient mice (2003)](https://pubmed.ncbi.nlm.nih.gov/14614075/)
Pathway Diagram The following diagram shows the key molecular relationships involving PLP1 Protein discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)
Show full description